Immatics (IMTX) Income - Equity (2023 - 2025)
Immatics (IMTX) posted Income - Equity of -$59.2 million for Q3 2025, up 26.65% sequentially from -$80.8 million in Q2 2025, and down 2193.38% YoY from $2.8 million in Q3 2024.
Immatics (IMTX) Income - Equity (2023 - 2025) Analysis & Trends
Immatics has reported Income - Equity for 3 years, with the latest figure at -$59.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income - Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -59.24 Mn |
| Jun 30, 2025 | -80.77 Mn |
| Mar 31, 2025 | -42.97 Mn |
| Sep 30, 2024 | -2.58 Mn |
| Jun 30, 2024 | -19.22 Mn |
| Mar 31, 2024 | -1.87 Mn |
| Sep 30, 2023 | -28.84 Mn |
| Jun 30, 2023 | -26.80 Mn |
| Mar 31, 2023 | -21.20 Mn |